Activation of insulin-like growth factor as a biomarker for cancer development and growth
Project/Area Number |
26460968
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Kyoto University |
Principal Investigator |
|
Research Collaborator |
SETOYAMA TAKESHI 京都大学, 医学部附属病院がんセンター, 医員 (80760595)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | インスリン様増殖因子 / バイオマーカー / 分子標的治療 / 非膵島細胞腫瘍性低血糖 / 活性型インスリン様増殖因子 / 肝転移 / 非膵島腫瘍性低血糖 / 中和抗体 / 分子標的療法 |
Outline of Final Research Achievements |
We have been reported the usefulness of insulin-like growth factor (IGF) as a therapeutic target using IGF neutralizing antibody. This antibody can neutralize only bioactive IGF activated in the tumor microenvironment and does not affect the physiological molecular form, IGF-IGF binding protein complex. This characteristics of antibody can lead to not only reduction of the systemic adverse effect but also tumor-specific drug delivery. It is essential for the accurate dosage adjustment and prediction of therapeutic and adverse effect to measure the level of bioactive IGF. We successfully develop the novel assay for the detection of bioactive IGF in the blood. Furthermore, we clarified that bioactive IGF-2 was elevated in a case of tumor-associated hypoglycemia except insulin-producing tumor using this assay.
|
Report
(4 results)
Research Products
(18 results)
-
-
[Journal Article] Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma.2016
Author(s)
Kikuchi, O, Ohashi, S, Horibe, T, Kohno, M, Nakai, Y, Miyamoto, S, Chiba, T, Muto, M and Kawakami, K
-
Journal Title
Scientific reports
Volume: 6
Issue: 1
Pages: 22452-22452
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
[Journal Article] Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer.2016
Author(s)
Tateya I, Muto M, Morita S, Miyamoto S, Hayashi T, Funakoshi M, Aoyama I, Higuchi H, Hirano S, Kitamura M, Ishikawa S, Kishimoto Y, Morita M, Ito J.
-
Journal Title
Surg Endosc.
Volume: 30
Issue: 1
Pages: 323-329
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium2015
Author(s)
Amanuma Y, Ohashi S, Itatani Y, Tsurumaki M, Matsuda S, Kikuchi1 O, Naka Y, Miyamoto S, Oyama T, Kawamoto T, Whelan KA, Nakagawa H, Chiba T, Matsuda T, Muto M
-
Journal Title
Scientific Reports
Volume: 5
Issue: 1
Pages: 14142-14142
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-